AzTrials
AzTrials

AsthmaNCT01345396

Influence of an Asthma Education Programme on Asthma Control During Pregnancy

A study testing Health education about asthma in people with Asthma, run by Centre Hospitalier Universitaire Saint Pierre at 1 site in Belgium.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Asthma is the most frequent respiratory disease during pregnancy. In a third of cases, the level of asthma control can decrease during the pregnancy, especially between the 29th and the 36th week. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Asthma
What is being tested?
Health education about asthma
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteBelgium
Study dates
Feb 2010to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Pregnant woman (less than 20 weeks of gestation at the inclusion time)
  • Diagnosis of asthma before the pregnancy (clinical history and specific medications used)
  • Agreement to enter into the study

Who cannot join

  • Pregnant woman (more than 20 weeks of gestation at the inclusion time)
  • History of major respiratory problems during previous pregnancy(ies)
  • Refusal to enter into the study

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • CHU St Pierre; pulmonology department

    Brussels

Other trials in Belgium

About this study

Official title: Assessment of an Educational Programme for Pregnant Asthmatic Women on the Level of Asthma Control and Unscheduled Doctor Visits During the Pregnancy

Asthma is the most frequent respiratory disease during pregnancy. In a third of cases, the level of asthma control can decrease during the pregnancy, especially between the 29th and the 36th week. The occurrence of such complications are linked with a high asthma severity level just before the conception and an history of respiratory complications in a previous pregnancy. Many reviews and recommendations claim that pregnant women with asthma should be included in an educational progamme. However, this is poorly studied. The purpose of this study is to observe if an educational programme given before the 20th weeks of gestation has an effect on asthma control until the end of gestation.

Conditions
Asthma
Being tested
Health education about asthma
Keywords
Asthma, Health education, Pregnancy
Medical subject headings
Asthma, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health education about asthmaBehavioural

    Three face-to-face appointments (<20, 36 weeks of gestation and 12 weeks after the baby birth). Topics: What is asthma? What influence the course of asthma? How to monitor it? How to manage it?

Study groups in NCT01345396
Study groupRoleWhat they receive
EducationExperimentalNot described
Receives: Behavioral: Health education about asthma
No educationNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The level of asthma control

    Assessment by the Asthma Control Questionnaire

    Measured: Inclusion (baseline), 36 weeks of gestation, 12 weeks post partum

Secondary outcomes (3)
  1. Number of unscheduled visits to the doctor for asthma

    Measured: Inclusion (baseline), 36 weeks of gestation, 12 weeks post partum

  2. Quality of life

    Asthma Quality of life questionnaire

    Measured: Inclusion (baseline), 36 weeks of gestation, 12 weeks post partum

  3. Knowledge about asthma

    Survey of asthma knowledge of French language Questionnaire de connaissance de l'asthme de langue française

    Measured: Inclusion (baseline), 36 weeks of gestation, 12 weeks post partum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2011 (estimated)
  2. Study startFeb 2010
  3. Primary completionFeb 2013
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01345396
Sponsor's protocol ID
B07620096465
Status last verified
Apr 2019
First submitted
28 Apr 2011
Last updated
4 Apr 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Health education about asthma in people with Asthma, run by Centre Hospitalier Universitaire Saint Pierre at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 4 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The level of asthma control (time frame: Inclusion (baseline), 36 weeks of gestation, 12 weeks post partum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in